# Therapeutic Drug Monitoring for Individualized Clozapine Therapy

> **NCT03523741** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Clozapine

## Key facts

- **NCT ID:** NCT03523741
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-13
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523741, "Therapeutic Drug Monitoring for Individualized Clozapine Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03523741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*